Anivive wins Best Animal Health Company by S&P Global
by Katie Pfaff
Anivive was named Best Animal Health Company of 2022 by S&P Global's Head of Animal Health for its annual North America award. Animal Health Connect by S&P Global, the most widely read publication reporting on the animal health industry, announced the award winners in late December 2022.
Anivive, a startup, joins a list of past recipients that include Zoetis, Merck and IDEXX, according to a news release.
Joseph Harvey, head of animal health at S&P Global, said that Anivive showed the most significant growth and innovation in 2022. According to the news release, Harvey cited Anivive's discovery software, clinical trial platform and ability to successfully develop and monetize products across an array of unmet needs as reasons for bestowing the award.
Anivive highlights from 2022 include receiving conditional approval from the FDA for an oral tablet to treat canine lymphoma. The startup also published efficacy data for and established a final formulation an anti-fungal vaccine. In addition, Anivive received FDA acceptance and conditional approval for an antiviral to treat feline infectious peritonitis.
In terms of software validation, the company completed a successful rollout of its first clinical trial recruitment platform and also received commercial validation of its first drug repurposing platform to identify human therapeutics to treat pets.
The Animal Health Awards are granted by a panel of industry expert judges to honor the achievements of companies who have had an outsized impact on the industry over the last 12 months.
Learn more about Anivive Lifesciences at https://www.anivive.com/
Comments
Related Articles
.jpg)
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment